RA Capital Nexus Fund II, L.P. - Insider Non-Derivative Transactions at ARS Pharmaceuticals, Inc. (SPRY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 21, 2023, RA Capital Nexus Fund II, L.P.'s relationship to ARS Pharmaceuticals, Inc. (SPRY) is Director, and currently has 8,556,774 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRY insiders.
Data Source: SEC.
RA Capital Nexus Fund II, L.P. - Insider Non-Derivative Transactions of SPRY Common Stock
RA Capital Nexus Fund II, L.P. - Insider Non-Derivative Transactions at SPRY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 22, 2023 | P -- (Common Stock) | 2508691 | 2.97 | 8365465 |
| Sep 22, 2023 | P -- (Common Stock) | 191309 | 3.83 | 8556774 |
| Aug 30, 2023 | P -- (Common Stock) | 3750000 | 6.2 | 5856774 |